Consun Pharmaceutical Group Ltd Sustainability Reports

Consun Pharmaceutical Group Limited researches, develops, manufactures, and markets modern Chinese medicines and medical contrast mediums. The company specifically focuses on pharmaceutical products for treating kidney diseases, orthopedics, and dermatological conditions.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 300300LQFLNDZZHCNN43

FIGI: BBG005P67Y50

16 reports from 2014 to 2025

• Consun Pharmaceutical Group Ltd 2025 Annual Report
• Consun Pharmaceutical Group Ltd 2025 Environmental, Social and Governance (ESG) Report
• Consun Pharmaceutical Group Ltd 2024 Annual Report
• Consun Pharmaceutical Group Ltd 2024 Environmental, Social and Governance (ESG) Report
• Consun Pharmaceutical Group Ltd 2023 Annual Report